1346-P: Obesity and Type 2 Diabetes in Patients with NAFLD Are Independently Associated with the Risk of Liver Fibrosis, Insulin Resistance, and Atherogenic Dyslipidemia

Obesity (OB) and type 2 diabetes (T2D) are associated with NAFLD and a worse cardiometabolic profile. However, their independent contribution to steatosis, fibrosis, insulin resistance (IR) and atherogenic dyslipidemia are controversial. To this end, we examined the prevalence of NAFLD and hepatic f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2022-06, Vol.71 (Supplement_1)
Hauptverfasser:	MATHEWS, APRIL, KALAVALAPALLI, SRILAXMI, GODINEZ, EDDISON, LOMONACO, ROMINA, DILLARD, RACHEL E., GONZALEZ, MARIA A., MARANGI, STEPHEN A., SHETTY, SHWETHA S., SHRESTHA, SULAV, MANSOUR, LYDIA, CONNELLY, MARGERY A., CHUN, KELLY Y., BARB, DIANA, CUSI, KENNETH
Format:	Artikel
Sprache:	eng
Schlagworte:	Adipose tissue Cardiovascular diseases Cirrhosis Diabetes Diabetes mellitus (non-insulin dependent) Dyslipidemia Endocrinology Fibrosis High density lipoprotein Insulin Insulin resistance Liver Low density lipoprotein Metabolic disorders Obesity Patients Primary care Steatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!